Canada · Delayed Price · Currency is CAD CCL Industries Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw 9.1% sales growth, strong operating income, and double-digit EPS gains, with robust segment performance in CCL, Avery, and Innovia. Shareholder returns were significant, and liquidity remains strong, though risks include chip shortages and resin price volatility.
-
Sales rose 2.8% to CAD 1.94B with solid organic growth and stable margins despite inflation. Strong segment performance in Europe and Asia, robust cash flow, and increased shareholder returns highlight the quarter. Inflation and macro risks remain key watchpoints.
Fiscal Year 2025
-
Sales and operating income grew in 2025, with record free cash flow and reduced net debt. CCL and Avery segments showed strong performance, while Checkpoint and Innovia faced mixed results. Outlook for 2026 includes stable growth, robust liquidity, and increased shareholder returns.
-
Q3 2025 saw 6.3% sales growth and 11% higher adjusted EPS, driven by strong CCL segment performance and favorable mix. Free cash flow and liquidity improved, while tariffs and supply chain volatility remain key risks. CapEx was revised down due to project delays.
-
Q2 2025 saw 4.8% sales growth and 8% higher adjusted EPS, with strong free cash flow and robust liquidity. Tariff-related supply chain disruptions impacted RFID and Checkpoint, while CCL and Innovia segments showed operational gains.
-
Q1 2025 saw 8.6% sales growth and record adjusted EPS, with strong free cash flow and robust liquidity. Segment performance was solid, though tariffs and U.S. back-to-school uncertainty pose risks, while new plant startups and global supply chain shifts offer opportunities.
Fiscal Year 2024
-
Q4 2024 saw 9% sales growth and a sharp rise in net income, driven by organic gains, acquisitions, and the absence of prior-year impairments. Segment performance was strong in most areas, with continued investment in capacity and a stable outlook amid macro uncertainties.
-
Sales grew 9.4% year-over-year in Q3 2024, with strong organic and acquisition-driven gains. Profitability improved across most segments, especially in RFID, while capital spending and share buybacks remained robust. Outlook is positive but faces tougher comps and startup costs.
-
Q2 2024 saw double-digit sales and profit growth, with strong organic and acquisition-driven gains across all segments. Free cash flow and liquidity remained robust, while RFID and label materials led segment outperformance. Outlook calls for continued growth, though comps will harden in Q4.